Drug Approval | January 28, 2024
Shilpa Medicare updates on Europe GMP inspection at Unit 4, Jadcherla, Telangana
The company intends to respond to the two minor observations within the stipulated time
The company intends to respond to the two minor observations within the stipulated time
The PAI was conducted for two drug product applications (ANDAs) filed from this facility
Microdosing has emerged as a key trend in the pharmaceutical and nutritional markets
Doxazosin tablets are indicated for the treatment of hypertension, to lower blood pressure
This investment will be made by Caplin Point Laboratories Limited and its subsidiaries - Caplin Steriles Limited and Caplin One Labs Limited
Dedicates upgraded National Centre for Disease Control, Delhi and a Temporary Regional Branch of NCDC to the nation
AMP-6 & AMP-8 are special purpose entities formed for purpose of setting up captive solar power projects in Karnataka
The company makes its maiden entry into Azerbaijan’s pharmaceutical market
The exclusive agreement also includes development, regulatory, and commercialization milestone payments based on the successful outcome
The findings of Phase 3 study are in line with Phase 2 study conducted in the US and Europe
Subscribe To Our Newsletter & Stay Updated
